MBX vs TSM Stock Comparison

MBX currently leads TSM in this stock comparison, with AIQ scores of 68 vs 67. The clearest difference is momentum, while TSM has the stronger risk resilience profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 1 points
MBX
Healthcare
vs
TSM
Technology
MBX
MBX Biosciences, Inc. Common Stock
Leads
Price
$55.94
Day move
+2.62%
AIQ Score
68/100
Best edge
Momentum
Sector
Healthcare
TSM
Taiwan Semiconductor Manufacturing Company Limited
Price
$399
Day move
-1.67%
AIQ Score
67/100
Best edge
Risk Resilience
Sector
Technology

What is the main difference between MBX and TSM?

MBX leads the current stock comparison as MBX Biosciences, Inc. Common Stock, with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

MBX Biosciences, Inc. Common Stock vs Taiwan Semiconductor Manufacturing Company Limited

Data as of Nov 15, 2026· market close· Cross-sector · Healthcare vs Technology· Coverage 64/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 2/10

MBX leads

MBX leads by 1 AIQ points, primarily on Momentum, having only recently taken the lead back from TSM.

Fragile: 2 of 5 evidence groups support MBX, the lead recently changed hands, and its signal state is cleanly positive.

Evidence agreement: 2 of 5Comparison trend: Reversed
MBX

MBX Biosciences, Inc. Common Stock

Leads
AIQ Score
68/100
AIQ Edge Score
10/10
TSM

Taiwan Semiconductor Manufacturing Company Limited

AIQ Score
67/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score currently favors MBX over TSM, 68 versus 67 as of Nov 15, 2026. MBX's advantage is driven primarily by stronger momentum, while TSM holds the stronger risk resilience profile. MBX also shows the stronger technical structure relative to its 50-day moving average. 2 of 5 covered evidence groups favor MBX today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 1 points. MBX lead: Reversed — TSM led by 4 AIQ points 30 sessions ago; MBX now leads by 1.

Compare MBX Biosciences, Inc. Common Stock and Taiwan Semiconductor Manufacturing Company Limited across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

MBX
+136.5%
TSM
+136.2%

Total return comparison

Growth of $10,000, distributions reinvested

MBX $23,653 · TSM $23,623

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare MBX and TSM against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

MBX advantage
0
TSM advantage
  • Risk Resilience50 vs 58
    TSM +8
  • Momentum71 vs 66
    MBX +5
  • Quality74 vs 74
    Even

2 of 5 evidence groups favor MBX. MBX’s edge is concentrated in momentum; TSM keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

MBX+1 AIQ

Largest factor move: Momentum +3

New signals

  • Accumulation Pattern — bullish, volume, medium horizon (1.59x)
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
TSM0 AIQ

Largest factor move: Momentum +2, not enough on its own to move the overall score.

New signals

  • Price Lost 200-Day MA — bearish, trend, long horizon

MBX's lead widened by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — MBX and TSM both carry a full feed there.

The central trade-off

MBX (MBX Biosciences, Inc. Common Stock): the stronger current systematic profile, led by momentum.

TSM (Taiwan Semiconductor Manufacturing Company Limited): the counter-case, on risk resilience, fundamentals.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

MBX

MBX on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

TSM

TSM on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

MBX

MBX on the Momentum factor, by 5 points.

Lower downside

TSM

TSM on Risk Resilience, by 8 points.

Analyst upside

MBX

MBX on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureMBXTSMNote
Implied upside to target+90.7%+44.5%MBX has more room
Target dispersion+61.9%+26.9%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1222Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

2 of 5 covered evidence groups favor MBX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEven68 vs 67
FundamentalsTSMEPS growth -65.4% vs 8%; TTM ROE -13.2% vs 10.9%
ValuationNot coveredNot covered
TechnicalsMBXPrice vs 50-day 0.3% vs -7.3%; vs 200-day 20.8% vs -1.1%
Risk ResilienceTSMRisk Resilience 50 vs 58
Analyst expectationsMBXTarget upside 90.7% vs 44.5%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of MBX and TSM and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 1 points. (argues the conclusion is provisional)
  • Only 2 of 5 covered evidence groups agree. (argues the conclusion is provisional)
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader's signal state is cleanly positive. (supports the conclusion holding)
  • Analyst targets on the leader are widely dispersed. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on MBX.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

MBX lead: Reversed — TSM led by 4 AIQ points 30 sessions ago; MBX now leads by 1.

May 27MBX leads above the line · TSM leads belowNov 13
Today
MBX +1
68 vs 67
7 sessions ago
TSM +1
67 vs 68
30 sessions ago
TSM +4
68 vs 72
90 sessions ago
MBX +7
75 vs 68

The lead changed hands once in this window, most recently on Oct 1 when TSM moved ahead of MBX.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

MBX

7 bullish / 0 bearish / 2 neutral

Only MBX

  • ADX Trend Weakening — neutral, trend, medium horizon
  • Accumulation Pattern — bullish, volume, medium horizon (1.59x)
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Price Reclaimed 50-Day MA — bullish, trend, medium horizon
  • TSI Bullish Crossover — bullish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon
TSMConflicted

2 bullish / 2 bearish / 1 neutral, conflicted

Only TSM

  • Price Lost 200-Day MA — bearish, trend, long horizon
  • Beta Spike Warning — bearish, risk_regime, long horizon

Both carry 3 more signals that do not separate them: Golden Cross Active, ATR Expansion - Breakout Mode, MACD Histogram Expanding Bullish.

TSM is conflicted, so the timing case there is weaker than the score alone suggests.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

MBXConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +2.62%, AIQ +1 points).

TSMNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.67%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1TSM closes the Momentum gap — currently 5 points behind, the largest single contributor to MBX's edge.
  2. 2TSM's Price Lost 200-Day MA resolves — a bearish trend rule currently active against it.
  3. 3MBX's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

TSM leads on balance
MetricMBXTSM
Revenue growth (YoY)0%17.6%
EPS growth (YoY)-65.4%8%
Gross margin0%65.8%
Operating margin0%57.9%
Return on equity (TTM)-13.2%10.9%
Debt to equity0.010.14

Performance

MBX leads 5 of 6 windows
MetricMBXTSM
1 week (5 sessions)8.9%6.2%
1 month (20 sessions)12.8%-3.4%
3 months (63 sessions)-18%-7.5%
6 months (126 sessions)72.4%-1.4%
Year to date77.4%31.2%
1 year (252 sessions)127.4%37.2%

Technicals

MBX has the stronger structure
MetricMBXTSM
RSI (14)53.345.3
ADX (14)13.729.2
Price vs 50-day0.3%-7.3%
Price vs 200-day20.8%-1.1%
Volatility (1M, annualized)68.2%61.7%

Risk

TSM is the more resilient
MetricMBXTSM
Beta1.262.16
Sharpe ratio1.420.95
Sortino ratio2.431.37
Max drawdown-37.6%-27.3%
Current drawdown-20.9%-17.9%
Annualized volatility77.3%41.8%
Value at risk (95%)-7.1%-4.2%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, MBX or TSM?

On the Algovestiq AIQ Score, MBX is the stronger of the two as of Nov 15, 2026, scoring 68 against TSM's 67. The edge comes from momentum. TSM is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is MBX or TSM the better buy right now?

MBX carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 2 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 1 points. Treat the lead as provisional.

Why does the AIQ Score favor MBX over TSM?

The composite weights Quality, Value, Momentum and Risk Resilience. TSM leads Risk Resilience by 8 points; MBX leads Momentum by 5 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, MBX or TSM?

Analyst price targets imply +90.7% upside for MBX and +44.5% for TSM, so the Street currently favors MBX. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, MBX or TSM?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, MBX or TSM?

TSM on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, MBX or TSM?

MBX on the Momentum factor, by 5 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, MBX or TSM?

TSM is the more resilient of the two, so the other name carries the higher downside risk. TSM on Risk Resilience, by 8 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is MBX more profitable than TSM?

TSM leads on the comparable margin measures — gross margin 0% vs 65.8%; operating margin 0% vs 57.9%; ttm roe -13.2% vs 10.9%.

Is MBX's lead over TSM getting stronger or weaker?

MBX lead: Reversed — TSM led by 4 AIQ points 30 sessions ago; MBX now leads by 1. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-10-01, when TSM moved ahead of MBX.

What would change the MBX vs TSM verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: TSM closes the Momentum gap — currently 5 points behind, the largest single contributor to MBX's edge; TSM's Price Lost 200-Day MA resolves — a bearish trend rule currently active against it; MBX's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about MBX and TSM?

MBX: 7 bullish / 0 bearish / 2 neutral. TSM: 2 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on MBX is Golden Cross Active (bullish, long horizon). On TSM it is Golden Cross Active (bullish, long horizon).

Compare MBX and TSM with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.